Novofem (Estradiol | Norethisterone Acetate, Estradiol)

Estradiol, the active ingredient in Novofem, is a combined oral contraceptive presented as a tablet for oral use. It is used to prevent pregnancy and to manage menstrual disorders in women of reproductive age.\nGNH India supplies Novofem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Novofem is a combined estrogen‑progestogen oral tablet that acts on the hypothalamic‑pituitary‑ovarian axis to prevent ovulation and regulate the menstrual cycle.\n\n- Contraception: provides reliable prevention of pregnancy when taken as directed.\n- Menstrual cycle regulation: reduces irregular bleeding and stabilises cycle length.\n- Dysmenorrhea management: alleviates painful menstrual cramps.\n- Acne associated with hormonal fluctuations: improves skin lesions.\n- Endometriosis symptom control: lessens pelvic pain and lesion progression.

Novofem may cause a range of adverse reactions, most of which are mild and transient.\n\nCommon Side Effects:\n- Nausea: mild to moderate stomach upset.\n- Breast tenderness: swelling or discomfort of the breasts.\n- Headache: occasional tension‑type headaches.\n- Weight gain: slight increase in body weight.\n- Mood changes: irritability or emotional fluctuations.\n- Breakthrough bleeding: spotting between periods.\n\nSerious or Rare Side Effects:\n- Venous thromboembolism: deep‑vein thrombosis or pulmonary embolism.\n- Arterial thrombosis: stroke or myocardial infarction.\n- Hypertension: new or worsening high blood pressure.\n- Liver dysfunction: abnormal liver enzymes or cholestasis.\n- Gallbladder disease: formation of gallstones.\n- Severe allergic reaction: rash, swelling, or anaphylaxis.

Before prescribing Novofem, clinicians should consider several safety aspects.\n\n- Cardiovascular risk assessment: evaluate history of thrombosis, hypertension, or smoking.\n- Liver function evaluation: avoid use in active liver disease.\n- Breast cancer screening: contraindicated in current or past breast malignancy.\n- Migraine history: caution in patients with migraine with aura.\n- Pregnancy testing: ensure patient is not pregnant before initiation.\n- Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Novofem can interact with other medicines, altering its effectiveness or safety.\n\nMajor Interactions (Avoid):\n- Enzyme‑inducing anticonvulsants (e.g., carbamazepine, phenytoin): reduce contraceptive efficacy.\n- Rifampicin and other rifamycins: markedly decrease hormone levels.\n- Certain antiretrovirals (e.g., efavirenz): lower contraceptive protection.\n- St. John's wort: may diminish hormonal activity.\n\nModerate Interactions (Monitor Closely):\n- Broad‑spectrum antibiotics (e.g., tetracyclines, macrolides): possible reduced effectiveness.\n- Antifungal agents (e.g., ketoconazole, itraconazole): may increase hormone concentrations.\n- Diuretics: may affect fluid balance and blood pressure.\n- SSRIs and SNRIs: monitor for mood changes.\n- Herbal supplements (e.g., ginseng): watch for altered hormone metabolism.